NovoCure (NVCR) Inventory (2014 - 2026)

NovoCure has disclosed Inventory across 13 years of filings, most recently posting $43.5 million for Q1 2026.

• Inventory for Q1 2026 came in at $43.5 million, up 10.11% year-over-year; the trailing twelve-month figure through Mar 2026 was $43.5 million (up 10.11% YoY), and the FY2025 annual result was $41.1 million, up 17.17% from the prior year.
• Inventory came in at $43.5 million for Q1 2026 at NovoCure, up from $41.1 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $43.5 million in Q1 2026 to a low of $26.8 million in Q3 2022.
• The 5-year median for Inventory is $38.2 million (2023), against an average of $36.2 million.
• Across the five-year window, Inventory soared 37.38% in 2023 and declined 8.04% in 2024, its largest moves.
• NovoCure's Inventory stood at $29.4 million in 2022, then grew by 29.87% to $38.2 million in 2023, then retreated by 8.04% to $35.1 million in 2024, then gained by 17.17% to $41.1 million in 2025, then climbed by 5.71% to $43.5 million in 2026.
• The last three Inventory figures came in at $43.5 million (Q1 2026), $41.1 million (Q4 2025), and $39.1 million (Q3 2025), per Business Quant data.